Antidepressants
DXM combinations with substances in this group.
PHI is a provisional hazard rating for a combination with DXM on a 0–10 scale.
- No PHI rating
Why is there no PHI rating?
The review gives this DXM combination no PHI. Mirtazapine, buspirone, triptans and cyclobenzaprine differ in pharmacology and main concerns.
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
Also belongs to this group
Find combinations by mechanism
Here the combinations are grouped by interaction mechanism.
Serotonin-related (7)
- DXM + Clomipramine and other tricyclic antidepressants (TCAs)PHI 6 to 8
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
- DXM + Fluoxetine, paroxetinePHI 7 to 8
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
- DXM + Sertraline, escitalopram, citalopram, fluvoxaminePHI 6 to 7
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
- DXM + Venlafaxine, desvenlafaxinePHI 6 to 7
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
Cardiovascular and thermal (3)
- DXM + Clomipramine and other tricyclic antidepressants (TCAs)PHI 6 to 8
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
- DXM + Venlafaxine, desvenlafaxinePHI 6 to 7
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
Sedation and respiration (1)
Metabolism (3)
- DXM + Fluoxetine, paroxetinePHI 7 to 8
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
NMDA
This category is not marked in the review
Antimuscarinic (1)
- DXM + Clomipramine and other tricyclic antidepressants (TCAs)PHI 6 to 8
Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
Seizure-related concern
This category is not marked in the review
Other discussed pathways
This category is not marked in the review